#chr	pos(1-coor)	ref	alt	aaref	aaalt	rs_dbSNP147	hg18_pos(1-coor)	hg38_chr	hg38_pos	genename	Uniprot_acc	Uniprot_id	Uniprot_aapos	Interpro_domain	cds_strand	refcodon	SLR_test_statistic 	codonpos	fold-degenerate	Ancestral_allele	Ensembl_geneid	Ensembl_transcriptid	aapos	aapos_SIFT	aapos_FATHMM	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_rankscore	FATHMM_pred	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	Reliability_index	VEST3_score	VEST3_rankscore	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	REVEL_score	REVEL_rankscore	MutPred_score	MutPred_rankscore	MutPred_protID	MutPred_AAchange	MutPred_Top5features	Eigen_coding_or_noncoding	Eigen-raw	Eigen-phred	Eigen-PC-raw	Eigen-PC-phred	Eigen-PC-raw_rankscore	CADD_raw	CADD_raw_rankscore	CADD_phred	GERP++_NR	GERP++_RS	GERP++_RS_rankscore	phyloP46way_primate	phyloP46way_primate_rankscore	phyloP46way_placental	phyloP46way_placental_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phastCons46way_primate	phastCons46way_primate_rankscore	phastCons46way_placental	phastCons46way_placental_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	SiPhy_29way_pi	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	LRT_Omega	UniSNP_ids	1000Gp1_AC	1000Gp1_AF	1000Gp1_AFR_AC	1000Gp1_AFR_AF	1000Gp1_EUR_AC	1000Gp1_EUR_AF	1000Gp1_AMR_AC	1000Gp1_AMR_AF	1000Gp1_ASN_AC	1000Gp1_ASN_AF	ESP6500_AA_AF	ESP6500_EA_AF 	ARIC5606_AA_AC	ARIC5606_AA_AF	ARIC5606_EA_AC	ARIC5606_EA_AF	ExAC_AC	ExAC_AF	ExAC_Adj_AC	ExAC_Adj_AF	ExAC_AFR_AC	ExAC_AFR_AF	ExAC_AMR_AC	ExAC_AMR_AF	ExAC_EAS_AC	ExAC_EAS_AF	ExAC_FIN_AC	ExAC_FIN_AF	ExAC_NFE_AC	ExAC_NFE_AF	ExAC_SAS_AC	ExAC_SAS_AF	clinvar_rs	clinvar_clnsig	clinvar_trait	clinvar_golden_stars	COSMIC_ID	COSMIC_CNT 
1	69395	G	A	G	E	rs759217511	59258	.	69395	OR4F5	Q8NH21	OR4F5_HUMAN	102	GPCR, rhodopsin-like superfamily (1);	+	GGG	.	2	0	.	ENSG00000186092	ENST00000534990;ENST00000335137	150;102	ENSP00000334393:G102E	ENSP00000334393:G102E	.;0.0	0.90636	.;D	1.0	0.89917	D	0.998	0.87578	D	0.000507	0.43919	D	0.999996	0.09067	N	2.98	0.85747	M	2.95	0.09723	T	-1.1066	0.03157	T	0.0821	0.32194	T	10	0.651	0.66765	.;-7.56	0.95064	.;D	0.00449104708741	0.11550	T	0.104	0.32697	0.697	0.83583	Q8NH21	G102E	Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.1903); Loss of helix (P = 0.2271); Loss of catalytic residue at H98 (P = 0.3509); Loss of glycosylation at S103 (P = 0.547)	c	0.198919208184028	3.298314	-0.00682954616033525	2.335939	0.41223	4.339116	0.59096	24.0	2.31	2.31	0.28768	0.398000	0.26397	1.232000	0.43678	0.034000	0.13776	0.943000	0.58893	0.997000	0.53966	0.000000	0.05858	0.0:0.2712:0.7288:0.0	7.503	0.27528	0.000000	.	.	1.780e-03	.	1.652e-04	.	2.547e-03	.	.	.	3.895e-04	.	.	.	.	.	.	2	2.267e-05	2	2.586e-05	0	0	0	0	0	0	2	5.643e-04	0	0	0	0	.	.	.	.	.	.
1	69409	A	G	I	V	rs764963650	59272	.	69409	OR4F5	Q8NH21	OR4F5_HUMAN	107	GPCR, rhodopsin-like superfamily (1);	+	ATC	.	1	0	.	ENSG00000186092	ENST00000534990;ENST00000335137	155;107	ENSP00000334393:I107V	ENSP00000334393:I107V	.;0.001	0.77262	.;D	0.008	0.13594	B	0.007	0.12156	B	0.097361	0.20188	N	1	0.09067	N	0.575	0.15343	N	7.57	0.00397	T	-0.9159	0.46884	T	0.0005	0.00178	T	10	0.156	0.19080	.;-0.92	0.24955	.;N	0.0019154081385	0.03789	T	0.053	0.17588	0.565	0.68965	Q8NH21	I107V	Gain of catalytic residue at I107 (P = 0.2589); Gain of glycosylation at S103 (P = 0.4664); Loss of helix (P = 0.6555); Loss of MoRF binding (P = 0.7352); Loss of stability (P = 0.7658)	c	-0.744753327234236	0.7389519	-0.725729943671834	0.8628394	0.17703	0.792580	0.18195	9.418	2.31	0.892	0.19230	0.327000	0.21459	1.014000	0.39417	0.007000	0.13174	0.577000	0.36160	0.984000	0.44739	0.000000	0.05858	0.4779:0.2634:0.0:0.2587	2.6294	0.04939	0.368374	.	.	2.569e-03	.	1.25e-03	.	2.88e-04	.	.	.	3.69e-03	.	.	.	.	.	.	9	9.669e-05	9	1.134e-04	0	0	0	0	0	0	0	0	0	0	9	7.227e-04	.	.	.	.	.	.
1	69428	T	G	F	C	rs140739101	59291	.	69428	OR4F5	Q8NH21	OR4F5_HUMAN	113	GPCR, rhodopsin-like superfamily (1);	+	TTT	.	2	0	.	ENSG00000186092	ENST00000534990;ENST00000335137	161;113	ENSP00000334393:F113C	ENSP00000334393:F113C	.;0.013	0.52702	.;D	0.999	0.76494	D	0.984	0.74674	D	0.010181	0.30193	N	0.709423	0.29994	N	2.255	0.64359	M	6.85	0.00520	T	-0.9558	0.40534	T	0.0007	0.00241	T	10	0.261	0.32259	.;-5.05	0.82493	.;D	.	.	.	0.055	0.18297	.	.	.	.	.	c	0.19991963147405	3.302783	0.0291523972076779	2.461685	0.42902	4.099778	0.56112	23.7	2.31	0.891	0.19224	0.327000	0.21459	1.014000	0.39417	0.464000	0.21988	0.660000	0.38997	1.000000	0.80357	0.860000	0.29831	0.4833:0.0:0.0:0.5167	4.4914	0.11815	0.156294	.	.	0.12598	.	0.00025	.	1.598e-03	.	.	.	0.000125	0.003663	0.045707	.	.	.	.	2141	2.155e-02	1985	2.462e-02	20	2.553e-03	53	8.045e-03	0	0	166	4.624e-02	1668	4.058e-02	61	4.888e-03	.	.	.	.	.	.
1	69474	T	G	I	M	rs752034042	59337	.	69474	OR4F5	Q8NH21	OR4F5_HUMAN	128	GPCR, rhodopsin-like superfamily (1);	+	ATT	.	3	3	.	ENSG00000186092	ENST00000534990;ENST00000335137	176;128	ENSP00000334393:I128M	ENSP00000334393:I128M	.;0.015	0.51293	.;D	0.736	0.41041	P	0.221	0.36289	B	0.061759	0.22309	N	1	0.09067	N	3.16	0.88753	M	2.05	0.20738	T	-1.0163	0.24333	T	0.0533	0.22126	T	10	0.236	0.29389	.;-2.76	0.58334	.;D	0.00483139032114	0.12618	T	0.041	0.13115	0.494	0.58639	Q8NH21	I128M	Gain of glycosylation at T126 (P = 0.175); Gain of loop (P = 0.2045); Loss of stability (P = 0.3038); Loss of helix (P = 0.3949); Gain of catalytic residue at I128 (P = 0.4686)	c	-0.462907830834785	1.250508	-0.684097222838017	0.9226265	0.18814	2.456454	0.37257	19.19	2.31	-0.119	0.13543	0.327000	0.21459	0.119000	0.18210	-0.736000	0.04882	0.114000	0.19823	0.549000	0.28204	0.037000	0.19845	0.2586:0.3428:0.0:0.3986	2.0763	0.03625	0.310996	.	.	0.00002	.	0.69872	.	0.25874	.	.	.	0.6258	.	.	.	.	.	.	1	9.893e-06	1	1.234e-05	1	1.257e-04	0	0	0	0	0	0	0	0	0	0	.	.	.	.	.	.
1	69478	T	C	C	R	rs757310325	59341	.	69478	OR4F5	Q8NH21	OR4F5_HUMAN	130	GPCR, rhodopsin-like superfamily (1);	+	TGT	.	1	0	.	ENSG00000186092	ENST00000534990;ENST00000335137	178;130	ENSP00000334393:C130R	ENSP00000334393:C130R	.;0.072	0.33874	.;T	0.0	0.02656	B	0.0	0.01281	B	0.780815	0.06755	N	0.95311	0.26481	N	-0.895	0.01376	N	1.33	0.35048	T	-1.0329	0.18681	T	0.0255	0.10423	T	10	0.089	0.08888	.;0.21	0.05021	.;N	0.00832287901956	0.22546	T	0.042	0.13501	0.525	0.63356	Q8NH21	C130R	Gain of methylation at C130 (P = 0.0559); Loss of catalytic residue at I128 (P = 0.1092); Gain of solvent accessibility (P = 0.1422); Loss of glycosylation at T127 (P = 0.1929); Gain of loop (P = 0.2045)	c	-1.3258738923198	0.1509731	-1.34028453946515	0.1839315	0.04049	0.164880	0.11644	4.306	2.31	-2.63	0.06133	0.327000	0.21459	-0.252000	0.09528	-0.588000	0.05774	0.130000	0.20726	0.330000	0.25442	0.000000	0.05858	0.3602:0.3249:0.0:0.3149	2.4867	0.04601	1.128570	.	.	0.5262	.	0.3648	.	0.002255	.	.	.	0.025687	.	.	.	.	.	.	1	1.001e-05	1	1.235e-05	0	0	0	0	1	1.189e-04	0	0	0	0	0	0	.	.	.	.	.	.
1	69487	G	A	A	T	rs568226429	59350	.	69487	OR4F5	Q8NH21	OR4F5_HUMAN	133	GPCR, rhodopsin-like superfamily (1);	+	GCA	.	1	0	.	ENSG00000186092	ENST00000534990;ENST00000335137	181;133	ENSP00000334393:A133T	ENSP00000334393:A133T	.;0.398	0.09996	.;T	0.001	0.06786	B	0.001	0.04013	B	0.129958	0.18832	N	1	0.09067	N	-0.515	0.02553	N	1.25	0.36520	T	-1.0542	0.12578	T	0.0321	0.13243	T	10	0.127	0.14799	.;0.19	0.05196	.;N	0.00373615690868	0.09160	T	0.016	0.03336	0.452	0.51935	Q8NH21	A133T	Gain of glycosylation at A133 (P = 0.0406); Loss of helix (P = 0.2271); Loss of stability (P = 0.3543); Loss of sheet (P = 0.5184); Loss of catalytic residue at G131 (P = 0.5288)	c	-1.14996170538439	0.2644032	-1.17581844671354	0.3036258	0.06600	0.158853	0.11577	4.241	2.15	0.0488	0.14286	0.398000	0.26397	0.179000	0.19938	-0.074000	0.11450	0.029000	0.11900	0.360000	0.25837	0.000000	0.05858	0.3562:0.2617:0.3822:0.0	2.645	0.04981	0.390949	.	.	0.0258	.	0.000125	.	0.02478	.	.	.	0.25689	.	.	.	.	.	.	2	2.105e-05	2	2.482e-05	2	2.538e-04	0	0	0	0	0	0	0	0	0	0	.	.	.	.	.	.
1	69496	G	A	G	S	rs150690004	59359	.	69496	OR4F5	Q8NH21	OR4F5_HUMAN	136	GPCR, rhodopsin-like superfamily (1);	+	GGC	.	1	0	.	ENSG00000186092	ENST00000534990;ENST00000335137	184;136	ENSP00000334393:G136S	ENSP00000334393:G136S	.;0.404	0.09795	.;T	0.401	0.33198	B	0.061	0.25506	B	0.104026	0.19878	N	0.998481	0.22301	N	1.04	0.26276	L	8.78	0.00063	T	-1.0970	0.04191	T	0.0001	0.00039	T	10	0.29	0.35423	.;-1.39	0.34496	.;N	0.00252380434477	0.05499	T	0.043	0.13885	.	.	.	.	.	c	-0.879009211747588	0.5468866	-0.90774675702892	0.6097024	0.12839	0.970400	0.20046	10.49	2.31	2.31	0.28768	0.398000	0.26397	1.232000	0.43678	-0.769000	0.04710	0.034000	0.12701	0.512000	0.27736	0.000000	0.05858	0.0:0.0:1.0:0.0	10.7603	0.46261	0.377447	.	.	0.3698	.	0.24874	.	0.25421	.	.	.	0.02445	0.00604	2.96E-4	.	.	.	.	62	6.729e-04	59	7.382e-04	46	5.937e-03	11	1.675e-03	0	0	0	0	2	4.928e-05	0	0	.	.	.	.	.	.
1	69502	A	G	M	V	rs747952157	59365	.	69502	OR4F5	Q8NH21	OR4F5_HUMAN	138	GPCR, rhodopsin-like superfamily (1);	+	ATG	.	1	0	.	ENSG00000186092	ENST00000534990;ENST00000335137	186;138	ENSP00000334393:M138V	ENSP00000334393:M138V	.;1.0	0.00909	.;T	0.0	0.02656	B	0.0	0.01281	B	0.318441	0.14457	N	1	0.09067	N	-2.4	0.00074	N	1.41	0.33438	T	-0.9655	0.38564	T	0.0117	0.04227	T	10	0.057	0.04160	.;0.68	0.02387	.;N	0.00230634211467	0.04870	T	0.023	0.05963	0.398	0.43121	Q8NH21	M138V	Gain of catalytic residue at M138 (P = 0.1145); Loss of helix (P = 0.2271); Gain of glycosylation at T141 (P = 0.2559); Loss of sheet (P = 0.5184); Loss of MoRF binding (P = 0.6161)	c	-1.68170728180859	0.03933277	-1.60228600069488	0.07449874	0.01658	-2.795504	0.00175	0.001	2.31	-1.92	0.07618	-0.554000	0.04202	-0.121000	0.11787	0.098000	0.15189	0.043000	0.13939	0.684000	0.30055	0.000000	0.05858	0.4814:0.0:0.2988:0.2198	2.6928	0.05125	0.561939	.	.	0.5698	.	0.15478	.	0.000145	.	.	.	0.000258	.	.	.	.	.	.	1	1.134e-05	1	1.288e-05	0	0	0	0	0	0	0	0	0	0	1	8.050e-05	.	.	.	.	.	.
1	69508	G	T	V	F	rs771844395	59371	.	69508	OR4F5	Q8NH21	OR4F5_HUMAN	140	GPCR, rhodopsin-like superfamily (1);	+	GTC	.	1	0	.	ENSG00000186092	ENST00000534990;ENST00000335137	188;140	ENSP00000334393:V140F	ENSP00000334393:V140F	.;0.095	0.30175	.;T	0.6	0.37573	P	0.31	0.39805	B	0.063317	0.22196	N	0.997904	0.22620	N	1.19	0.30208	L	1.16	0.38077	T	-1.0657	0.09818	T	0.0638	0.26159	T	10	0.266	0.32817	.;-2.16	0.48742	.;N	0.00550049689789	0.14688	T	0.072	0.23909	0.707	0.84495	Q8NH21	V140F	Loss of helix (P = 0.2271); Loss of glycosylation at T141 (P = 0.3471); Loss of stability (P = 0.3797); Gain of sheet (P = 0.4423); Loss of catalytic residue at T141 (P = 0.4763)	c	-0.483250242769788	1.209681	-0.575381187674536	1.083494	0.21730	0.959801	0.19932	10.43	2.31	1.35	0.21983	0.398000	0.26397	1.232000	0.43678	0.033000	0.13754	0.093000	0.18481	0.994000	0.49952	0.000000	0.05858	0.1744:0.0:0.8256:0.0	6.2619	0.20905	0.313502	.	.	.	.	.	0.36987	.	0.2547	.	0.00000235	0.2647	.	.	.	.	.	.	2	2.274e-05	2	2.573e-05	0	0	0	0	0	0	0	0	2	5.135e-05	0	0	.	.	.	.	.	.
1	69509	T	G	V	G	rs773029983	59372	.	69509	OR4F5	Q8NH21	OR4F5_HUMAN	140	GPCR, rhodopsin-like superfamily (1);	+	GTC	.	2	0	.	ENSG00000186092	ENST00000534990;ENST00000335137	188;140	ENSP00000334393:V140G	ENSP00000334393:V140G	.;0.19	0.20268	.;T	0.042	0.20164	B	0.046	0.23419	B	0.063317	0.22196	N	0.8684	0.35349	D	-0.4	0.02970	N	1.21	0.37235	T	-1.0666	0.09618	T	0.0402	0.16727	T	10	0.261	0.32259	.;-2.59	0.55621	.;D	0.00534079116166	0.14200	T	0.067	0.22336	0.736	0.87034	Q8NH21	V140G	Loss of stability (P = 0.009); Loss of helix (P = 0.2271); Gain of glycosylation at T141 (P = 0.3633); Gain of sheet (P = 0.4423); Gain of catalytic residue at T141 (P = 0.4476)	c	-1.16024768898354	0.256359	-1.12932373663012	0.3464297	0.07496	-0.617526	0.04962	0.113	2.31	1.33	0.21861	-0.554000	0.04202	0.248000	0.21435	-0.619000	0.05572	0.092000	0.18411	0.993000	0.49108	0.000000	0.05858	0.0:0.8369:0.0:0.1631	7.0828	0.25241	0.313502	.	.	0.157876	.	0.000032	.	0.02548	.	.	.	0.001547	.	.	.	.	.	.	18	2.046e-04	4	5.195e-05	0	0	0	0	0	0	1	3.131e-04	3	7.793e-05	0	0	.	.	.	.	.	.
1	949523	C	T	Q	X	rs786201005	939386	.	1014143	ISG15	.	.	.	.	+	CAG	-16.7296	1	0	c	ENSG00000187608	ENST00000379389	55	ENSP00000368699:Q55X	.	.	.	.	.	.	.	.	.	.	0.351746	0.04327	N	1	0.80722	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	0.3374591189946	3.978393	0.00338913452261207	2.370765	0.41693	9.982687	0.96562	36	4.24	3.29	0.37713	0.555000	0.69702	1.107000	0.41642	-0.487000	0.06505	0.052000	0.14988	0.513000	0.27749	0.000000	0.05858	0.0:0.7925:0.2075:0.0	9.933	0.41534	1.368470	.	.	0.000028	.	0.3645	.	0.000154	.	.	.	0.002354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs786201005	5	Immunodeficiency 38 with basal ganglia calcification	0	.	.
1	955619	G	C	V	L	rs201073369	945482	.	1020239	AGRN	O00468	AGRIN_HUMAN	23	.	+	GTC	.	1	0	G	ENSG00000188157	ENST00000379370	23	ENSP00000368678:V23L	ENSP00000368678:V23L	0.632	0.04820	T	0.004	0.11235	B	0.006	0.11329	B	0.726910	0.10013	U	1	0.09067	N	0.14	0.08765	N	-0.9	0.75050	T	-0.9797	0.35226	T	0.1840	0.54143	T	10	0.159	0.19505	-0.25	0.11448	N	.	.	.	0.040	0.12726	.	.	.	.	.	c	-1.10990126718945	0.297743	-1.16109306244423	0.316724	0.06875	0.069819	0.10600	3.288	2.05	1.04	0.20106	0.466000	0.42574	0.172000	0.19760	1.457000	0.35212	0.044000	0.14063	0.013000	0.15412	0.007000	0.16637	0.142:0.0:0.858:0.0	7.9712	0.30127	0.737577	.	.	0.000248	.	0.3657	.	0.0001487	.	.	.	0.001245	.	.	.	.	.	.	314	1.364e-02	284	3.475e-02	3	1.271e-02	5	6.410e-02	1	8.929e-03	0	0	24	1.233e-02	247	4.324e-02	.	.	.	.	.	.
1	1464679	C	T	P	L	.	1454542	.	1529299	ATAD3A	.	.	.	.	+	CCG	.	2	0	c	ENSG00000197785	ENST00000339113	513	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.999998;0.999998;0.999998;0.999998;0.999998;0.999998	0.58240	D;D;D;D;D;D	.	.	.	.	.	.	0.6138	0.92657	D	0.7656	0.92622	D	5	.	.	.	.	.	0.34942152554	0.92548	D	0.163	0.44950	-	.	ENST00000339113	P513L	-	c	0.0186093160820871	2.577879	-0.179818301649222	1.834891	0.34060	5.932043	0.81753	27.6	4.26	2.35	0.29111	-0.517000	0.04412	0.436000	0.26393	1.327000	0.33746	0.015000	0.08874	0.949000	0.38748	0.465000	0.25815	0.3133:0.6867:0.0:0.0	12.0657	0.53586	.	.	.	0.36547	.	0.000017	.	0.1248	.	.	.	0.015489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
1	6027365	C	T	A	T	rs113765431	5949952	.	5967305	NPHP4	O75161	NPHP4_HUMAN	171	.	-	GCA	.	1	0	C	ENSG00000131697	ENST00000378156	171	ENSP00000367398:A171T	ENSP00000367398:A171T	0.057	0.36829	T	0.512	0.35612	P	0.039	0.22386	B	0.361843	0.04387	N	1	0.09067	N	0.69	0.16992	N	-2.17	0.86769	D	-0.6819	0.62604	T	0.1970	0.56217	T	10	0.017	0.00308	-0.3	0.12360	N	.	.	.	0.265	0.60371	.	.	.	.	.	c	-1.48731242853396	0.08512246	-1.61046842580758	0.07223338	0.01607	1.100055	0.21418	11.22	5.53	11.1	0.00147	-0.251000	0.11542	-2.529000	0.00492	-2.928000	0.00690	0.728000	0.41692	0.000000	0.03702	0.000000	0.05858	0.1506:0.502:0.2222:0.1252	6.4191	0.21734	1.443400	.	6	0.0027472527472527475	6	0.012195121951219513	0	0.0	0	0.0	0	0.0	0.011155	0.0	72	0.01499	0	0.01130	133	1.102e-03	114	1.994e-03	108	2.209e-02	2	5.311e-04	0	0	0	0	2	6.306e-05	2	2.035e-04	rs113765431	3|2	not provided|not specified	1|1	.	.
1	7869953	C	G	P	A	rs150812083	7792540	.	7809893	PER3	A2I2N5;A6H8X0;P56645-2;P56645	.;.;.;PER3_HUMAN	414;415;415;414	.	+	CCA	.	1	0	C	ENSG00000049246	ENST00000377532;ENST00000361923	415;414	.	ENSP00000366755:P415A;ENSP00000355031:P414A	0.0;0.0	0.90636	D;D	1.0;1.0;1.0;1.0	0.89917	D;D;D;D	0.998;0.999;1.0;0.998	0.97110	D;D;D;D	0.000000	0.85682	D	1;1	0.80722	D;D	3.31	0.90785	M	1.88;1.88	0.23950	T;T	-0.5911	0.66488	T	0.1622	0.50548	T	9	0.374	0.43904	-7.61;-7.61	0.95213	D;D	.	.	.	0.274	0.61473	.	.	.	.	.	c	0.748678581129836	7.857775	0.623629307651125	6.532055	0.78080	4.841413	0.65780	24.8	4.44	4.44	0.53790	0.650000	0.86243	2.315000	0.78130	6.688000	0.74557	0.437000	0.31866	0.888000	0.34837	1.000000	0.71417	0.0:1.0:0.0:0.0	16.2724	0.82628	0.000000	.	12	0.005494505494505495	1	0.0020325203252032522	9	0.011873350923482849	2	0.0055248618784530384	0	0.0	4.54E-4	0.00407	1	0.00021	49	0.00016	705	5.807e-03	695	5.886e-03	5	4.966e-04	10	8.832e-04	2	2.345e-04	176	2.883e-02	455	6.993e-03	44	2.728e-03	rs150812083	5	Advanced sleep phase syndrome, familial, 3	0	.	.
